# Filing Detail

Form DRS - Draft Registration Statement:
SEC Accession No. 0001213900-21-044387
Filing Date
2021-08-23
Accepted
2021-08-23 17:12:25
Documents
11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS | 1819833
2 | GRAPHIC | image_001.jpg | GRAPHIC | 5954
3 | GRAPHIC | image_002.jpg | GRAPHIC | 44918
4 | GRAPHIC | image_003.jpg | GRAPHIC | 46430
5 | GRAPHIC | image_004.jpg | GRAPHIC | 29609
6 | GRAPHIC | image_005.jpg | GRAPHIC | 33048
7 | GRAPHIC | image_006.jpg | GRAPHIC | 38536
8 | GRAPHIC | image_007.jpg | GRAPHIC | 30358
9 | GRAPHIC | image_008.jpg | GRAPHIC | 29116
10 | GRAPHIC | image_009.jpg | GRAPHIC | 27196
11 | GRAPHIC | image_010.jpg | GRAPHIC | 43581
| Complete submission text file | 0001213900-21-044387.txt |  | 2274871

Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

EIN.: 000000000
Type: DRS | Act: 33 | File No.: 377-05402 | Film No.: 211197676
SIC: 2836 Biological Products, (No Diagnostic Substances)